The Wire The issue of the deaths of 70 children in the Gambia after consuming cough syrup is back in the news again. These deaths were linked to four medicines made by an Indian manufacturer, Maiden Pharmaceuticals. A Gambian presidential task force has now recommended that the government must sue the drug manufacturer, Maiden Pharmaceuticals, and the drug importer, Atlantic Pharmaceuticals. It also wants the Government of India to be sued. This...
More »SEARCH RESULT
Total Matching Records found : 501
Poverty and inequality
KEY TRENDS • Oxfam India's 2023 India Supplement report on poverty and inequality in India reveals that the gap between the rich and the poor is widening. Following the pandemic in 2019, the bottom 50 per cent of the population have continued to see their wealth chipped away. By 2020, their income share was estimated to have fallen to only 13 per cent of the national income and have less than 3...
More »US FDA Flags Lapses by Indian Firm's Eye Drops Linked to Vision Loss and Deaths - Tabassum Barnagarwala
Scroll.in The US Food and Drug Administration has found a series of violations in the manufacturing process and sterilisation methods adopted by Global Pharma, the Indian manufacturer of an eye drop that has been linked to 68 cases of eye infection in America, including eight cases of vision loss and three deaths. The company recalled its product, EzriCare Artificial Tears Eye Drop, early in February. The over-the-counter product has been linked to...
More »WHO Drew Premature Link Between Gambia Child Deaths, Indian Cough Syrups: Drug Regulator
-PTI/ NDTV.com The DCGI said Gambia has informed, according to media, that there has been no direct causal relation established yet between the cough syrup consumption and the deaths. New Delhi: The WHO drew a premature link between the deaths of children in Gambia and the four India-made cough syrups which adversely impacted the image of the country's pharmaceutical products across the globe, India's drug regulator has told the global health body. In...
More »For Poor Manufacturing Practices, Indian Pharma Company Gets ‘Warning Letter’ From US FDA
-TheWire.in The US drug regulator says Lupin Limited's response to tackling genotoxic impurities was not adequate. New Delhi: The US Food and Drug Administration (FDA) has sent a warning letter to the Indian Pharmaceutical company Lupin Limited after deeming its efforts to address violations of various good manufacturing practices at its facility in Tarapur, Maharashtra “inadequate”. The FDA sends a ‘warning letter’ to a manufacturer if it has “significantly violated” the agency’s regulations....
More »
